Frequency Mood and Sleep Disorders in Patients With Central Nervous System Hemangioblastoma After Surgery

Any type of tumor is considered as an insidious risk to life, and its early diagnosis can be effective in the treatment and recovery process. Several factors challenge the early diagnosis of brain tumors. Since psychiatric symptoms do not reflect the pathogenomic characteristics of brain tumors, the underlying organic cause may be overlooked. The present study was conducted with the aim of determining mood and sleep disorders in patients with central nervous system hemangioblastoma after surgery.

This descriptive-cross-sectional study included 32 patients with hemangioblastoma who underwent surgical treatment between 2016 and 2016. Patient information was collected by checklists and standard questionnaires. Karnofsky's and ECOG functional status scales, Brunel's mood scale and short sleep questionnaire MSQ were used to evaluate the performance status.

The age of the patients was 44.28±15.15 years and 18 (56.3%) were male. The follow-up time of the patients was 6.71±3.57 years. Also, the average tumor size was 35.4±12.98 mm. 9 patients (28.1%) underwent radiotherapy in addition to surgery and 5 patients (15.6%) underwent chemotherapy. Functional status of Karnofsky and ECOG was optimal. Sleep disorders indicate moderate sleep and wakefulness problems, and all dimensions of mood disorders (tension, depression, anger, fatigue, vitality, and confusion) were more than average.

In the present study, as in other studies, depression and tension were important mood factors in brain tumor patients. In addition, they had a significant impact on the patients' functional status. In this regard, it is suggested to conduct more detailed and comprehensive studies on the psychological disorders of patients with any type of brain tumor and to consider psychological treatments as part of the treatment process for these patients.